Mi Deng

City:

Plano, Texas

Country:

United States

Published Applications:

Last publication date:

2026-05-28

Top Assignees for applications by Mi Deng

The entities that hold a legal rights for patent applications filed by inventor Deng Mi:

The Board of Regents of the University of Texas System 7 Austin, TX United States
FRED HUTCHINSON CANCER RESEARCH CENTER 2 Seattle, WA United States
Board of Regents of the University of Texas System 2 Austin, TX United States

Recent patent applications by Deng Mi

Mi Deng from Plano, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-05-28

US20260146072A1

Chemistry; metallurgy

TARGETING LILRB4 WITH CAR-T OR CAR-NK CELLS IN THE TREATMENT OF CANCER

#2 | 2021-11-11

US20210349096A1

Physics

Methods for identifying LILRB-blocking antibodies

#3 | 2021-06-17

US20210179687A1

Chemistry; metallurgy

TARGETING LILRB4 WITH CAR-T OR CAR-NK CELLS IN THE TREATMENT OF CANCER

#4 | 2020-03-12

US20200079851A1

Chemistry; metallurgy

Anti-LILRB antibodies and their use in detecting and treating cancer

#5 | 2019-11-07

US20190338026A1

Chemistry; metallurgy

Anti-leukocyte-associated immunoglobulin-like receptor 1 (LAIR1) monoclonal antibodies and method of use thereof to treat cancer

#6 | 2019-10-31

US20190330593A1

Chemistry; metallurgy

LILRB2 AND NOTCH-MEDIATED EXPANSION OF HEMATOPOIETIC PRECURSOR CELLS

#7 | 2018-03-29

US20180086829A1

Chemistry; metallurgy

Anti-LILRB antibodies and their use in detecting and treating cancer

#8 | 2017-10-26

US20170304240A1

Human necessities

Compounds supports hematopoietic stem cells and red blood cells

#9 | 2017-09-14

US20170260508A1

Chemistry; metallurgy

LILRB2 and notch-mediated expansion of hematopoietic precursor cells

InventorID:

1981940 ⎘